These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31210916)

  • 1. Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study.
    Dehpouri T; Rokni GR; Narenjbon NA; Goldust M; Yamauchi PS; Wollina U; Lotti T; Kircik L; Lernia VGD; Sonthalia S; Vojvodic A; Szepietowski J; Bahadoran P; Errichetti E; Cantisani C; Atzori L; Rezaee E; Kutlubay Z; Engin B; Nisticò S; Damiani G; Conic RRZ; Goren A; Čabrijan L; Tchernev G
    Dermatol Reports; 2019 Jan; 11(1):7965. PubMed ID: 31210916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of 25-hydroxyvitamin D serum levels and metabolic parameters in psoriatic patients with and without arthritis.
    Orgaz-Molina J; Magro-Checa C; Rosales-Alexander JL; Arrabal-Polo MA; Buendía-Eisman A; Raya-Alvarez E; Arias-Santiago S
    J Am Acad Dermatol; 2013 Dec; 69(6):938-46. PubMed ID: 24094453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis.
    Bostoen J; Van Praet L; Brochez L; Mielants H; Lambert J
    J Eur Acad Dermatol Venereol; 2014 Apr; 28(4):507-11. PubMed ID: 24772493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A.
    Gül U; Gönül M; Kiliç A; Erdem R; Cakmak SK; Gündüz H
    Clin Ther; 2006 Feb; 28(2):251-4. PubMed ID: 16678646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
    Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis.
    Kane D; Roth J; Frosch M; Vogl T; Bresnihan B; FitzGerald O
    Arthritis Rheum; 2003 Jun; 48(6):1676-85. PubMed ID: 12794836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines.
    Busger Op Vollenbroek FTM; Doggen CJM; Janssens RWA; Bernelot Moens HJ
    PLoS One; 2018; 13(3):e0194401. PubMed ID: 29570708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis.
    Behrens F; Koehm M; Schwaneck EC; Schmalzing M; Wittig BM; Gnann H; Greger G; Tony HP; Burkhardt H
    Scand J Rheumatol; 2019 Sep; 48(5):375-382. PubMed ID: 31311386
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
    Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis--short- and long-term toxicity in 104 patients.
    Wollina U; Ständer K; Barta U
    Clin Rheumatol; 2001; 20(6):406-10. PubMed ID: 11771523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients.
    Simon D; Kleyer A; Bayat S; Tascilar K; Kampylafka E; Meinderink T; Schuster L; Petrov R; Liphardt AM; Rech J; Schett G; Hueber AJ
    Arthritis Res Ther; 2019 Jul; 21(1):162. PubMed ID: 31269973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate.
    van Mens LJJ; de Jong HM; Fluri I; Nurmohamed MT; van de Sande MGH; Kok M; van Kuijk AWR; Baeten D
    Ann Rheum Dis; 2019 May; 78(5):610-616. PubMed ID: 30808625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
    Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
    Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis.
    Deyab G; Hokstad I; Whist JE; Smastuen MC; Agewall S; Lyberg T; Ronda N; Mikkelsen K; Hjeltnes G; Hollan I
    Arthritis Res Ther; 2017 Oct; 19(1):232. PubMed ID: 29041979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate-Related Liver Cirrhosis in Psoriatic Arthritis: A Case Report and Review of the Literature.
    Koutsompina ML; Pappa M; Sakellariou S; Gialouri CG; Fragoulis GE; Androutsakos T
    Mediterr J Rheumatol; 2021 Sep; 32(3):264-272. PubMed ID: 34964031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should Methotrexate Have Any Place in the Treatment of Psoriatic Arthritis?
    Ye W; Coates LC
    Rheum Dis Clin North Am; 2019 Aug; 45(3):325-339. PubMed ID: 31277747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate achieves major cDAPSA response, and improvement in dactylitis and functional status in psoriatic arthritis.
    Appani SK; Devarasetti PK; Irlapati RVP; Rajasekhar L
    Rheumatology (Oxford); 2019 May; 58(5):869-873. PubMed ID: 30590763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Woolacott N; Bravo Vergel Y; Hawkins N; Kainth A; Khadjesari Z; Misso K; Light K; Asseburg C; Palmer S; Claxton K; Bruce I; Sculpher M; Riemsma R
    Health Technol Assess; 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239. PubMed ID: 16948890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of methotrexate in management of peripheral psoriatic arthritis - a systematic review.
    Ruhoff JT; Horn HC; Ellingsen T
    Dan Med J; 2019 Oct; 66(10):. PubMed ID: 31571573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.